Workflow
海翔药业: 关于实际控制人办理股票质押式回购延期业务的公告

Group 1 - Zhejiang Haixiang Pharmaceutical Co., Ltd. has received notification from its actual controller, Mr. Wang Yunfu, regarding the extension of stock pledge repurchase transactions conducted through CITIC Securities Co., Ltd. [1] - The stock pledge repurchase extension involves a total of 39.32% of the company's total share capital, with 2.89% of shares pledged for repurchase [1]. - As of the announcement date, Mr. Wang Yunfu, Mr. Wang Yangchao, and Zhejiang Donggang Industrial Co., Ltd. have a total of 644,828,587 pledged shares, accounting for 39.84% of the company's total share capital [2][3]. Group 2 - Mr. Wang Yunfu holds 118,800,000 shares, representing 7.34% of the total shares, with 46,710,000 shares pledged, which is 39.32% of his holdings [1]. - Mr. Wang Yangchao has pledged 2,046,000 shares, accounting for 0.13% of the total shares [2]. - Zhejiang Donggang Industrial Co., Ltd. has pledged 523,982,587 shares, which is 32.37% of its holdings [3].